UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Blood, 2022-09, Vol.140 (11), p.1200-1228

2022

Volltextzugriff (PDF)

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms

BMC cancer, 2019-02, Vol.19 (1), p.184-9, Article 184

2019

Volltextzugriff (PDF)

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

Blood cancer journal (New York), 2018-02, Vol.8 (2), p.15-11, Article 15

2018

Volltextzugriff (PDF)

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Blood, 2009-07, Vol.114 (5), p.937-951

2009

Volltextzugriff (PDF)

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Leukemia, 2021-02, Vol.35 (2), p.485-493

2021

Volltextzugriff (PDF)

Myeloproliferative Neoplasms

The New England journal of medicine, 2017-06, Vol.376 (22), p.2168-2181

2017

Volltextzugriff (PDF)

Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey

BMC cancer, 2016-02, Vol.16 (167), p.167-167, Article 167

2016

Volltextzugriff (PDF)

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Blood, 2016-05, Vol.127 (20), p.2391-2405

2016

Volltextzugriff (PDF)

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12

British journal of haematology, 2016-08, Vol.174 (3), p.382-396

2016

Volltextzugriff (PDF)

PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells

Blood, 2018-09, Vol.132 (11), p.1095-1105

2018

Volltextzugriff (PDF)

Heterodimeric JAK―STAT activation as a mechanism of persistence to JAK2 inhibitor therapy

Nature (London), 2012-09, Vol.489 (7414), p.155-159

2012

Volltextzugriff (PDF)

Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants

Blood, 2016-03, Vol.127 (10), p.1325-1335

2016

Volltextzugriff (PDF)

Myeloproliferative Neoplasms: A Contemporary Review

JAMA oncology, 2015-04, Vol.1 (1), p.97

2015

Volltextzugriff (PDF)

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

Blood, 2014-04, Vol.123 (14), p.2220-2228

2014

Volltextzugriff (PDF)

Relating NF-κB regulation to MPN pathogenesis

Blood, 2024-06, Vol.143 (23), p.2345

2024

Volltextzugriff (PDF)

Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature

British journal of haematology, 2024-07, Vol.205 (1), p.48-60

2024

Volltextzugriff (PDF)

Myeloid neoplasms with eosinophilia

Blood, 2017-02, Vol.129 (6), p.704-714

2017

Volltextzugriff (PDF)

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

Leukemia, 2021-04, Vol.35 (4), p.935-955

2021

Volltextzugriff (PDF)

JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response

Cancer discovery, 2015-03, Vol.5 (3), p.316-331

2015

Volltextzugriff (PDF)

Accelerated Phase of Myeloproliferative Neoplasms

Acta haematologica, 2021-01, Vol.144 (5), p.484-499

2021

Volltextzugriff (PDF)

Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

Leukemia, 2020-04, Vol.34 (4), p.1062-1074

2020

Volltextzugriff (PDF)

Antibody targeting of mutant calreticulin in myeloproliferative neoplasms

Journal of cellular and molecular medicine, 2024-03, Vol.28 (5), p.e17896-n/a

2024

Volltextzugriff (PDF)

JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells

British journal of haematology, 2015-10, Vol.171 (1), p.60-73

2015

Volltextzugriff (PDF)

Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma

American journal of hematology, 2024-09, Vol.99 (9), p.1827-1829

2024

Volltextzugriff (PDF)

1 – 25 von 8.205

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.711)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(7.187)
Science & Technology
(5.775)
Life Sciences & Biomedicine
(5.616)
Hematology
(3.371)
Male
(2.883)
Myeloproliferative Disorders - Genetics
(2.863)
Female
(2.797)
Middle Aged
(2.205)
Aged
(1.958)
Adult
(1.885)
Oncology
(1.845)
Mutation
(1.809)
Myeloproliferative Disorders
(1.677)
Myeloproliferative Disorders - Pathology
(1.513)
Biological And Medical Sciences
(1.393)
Medical Sciences
(1.346)
Myeloproliferative Disorders - Diagnosis
(1.329)
Janus Kinase 2 - Genetics
(1.270)
Myeloproliferative Disorders - Complications
(1.108)
Animals
(1.069)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(7.565)
EZB Electronic Journals Library
(3.857)
Journals@Ovid Full Text
(2.929)
Ingenta
(2.498)
NUS Single-Journal Subscriptions
(1.582)
Wiley Blackwell Single Titles
(1.282)
Elsevier ScienceDirect Journals Complete
(1.181)
Wiley Online Library Full Collection 2018
(1.171)
IngentaConnect Journals
(1.064)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(726)
Springer Journals
(646)
Nature Journals Online
(602)
Nexis Uni
(525)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(478)
Taylor & Francis Journals Auto-Holdings Collection
(393)
Taylor & Francis
(370)
Taylor & Francis E-Journals
(337)
SpringerLink Series
(122)
Thieme - Connect here FIRST to enable access
(109)
BMJ
(99)
Oxford Journals
(0)

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Myeloproliferative Neoplasms

Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12

PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells

Heterodimeric JAK―STAT activation as a mechanism of persistence to JAK2 inhibitor therapy

Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants

Myeloproliferative Neoplasms: A Contemporary Review

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

Relating NF-κB regulation to MPN pathogenesis

Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature

Myeloid neoplasms with eosinophilia

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response

Accelerated Phase of Myeloproliferative Neoplasms

Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

Antibody targeting of mutant calreticulin in myeloproliferative neoplasms

JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells

Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma

Aktive Filter

Suchergebnisse filtern